The role of TNF-α and anti-TNF-α agents in the immunopathogenesis and management of immune dysregulation in primary immunodeficiency diseases

被引:11
作者
Abubakar, Sharafudeen Dahiru [1 ,2 ]
Ihim, Stella Amarachi [3 ,4 ]
Farshchi, Amir [5 ]
Maleknia, Shayan [5 ]
Abdullahi, Hamisu [6 ]
Sasaki, Takanori [7 ,8 ]
Azizi, Gholamreza [9 ]
机构
[1] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Tokyo, Japan
[2] Ahmadu Bello Univ, Coll Med Sci, Dept Med Lab Sci, Zaria, Nigeria
[3] Univ Shizuoka, Dept Mol & Cellular Pharmacol, Shizuoka, Japan
[4] Univ Nigeria, Dept Pharmacol & Toxicol, Nsukka, Nigeria
[5] Alborz Univ Med Sci, Biopharmaceut Res Ctr, AryoGen Pharmed Inc, Karaj, Iran
[6] Usmanu Danfodiyo Univ Sokoto, Sch Med Lab Sci, Dept Immunol, Sokoto, Nigeria
[7] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA
[8] Keio Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan
[9] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran
关键词
Primary immunodeficiency diseases; common variable immunodeficiency; autoimmune diseases; inflammatory diseases; tumor necrosis factor alpha; infliximab; etanercept; adalimumab; TUMOR-NECROSIS-FACTOR; COMMON VARIABLE IMMUNODEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY; CROHNS-LIKE DISEASE; GRANULOMATOUS-DISEASE; T-CELLS; PYODERMA-GANGRENOSUM; CUTANEOUS GRANULOMAS; INFLIXIMAB; SUPERFAMILY;
D O I
10.1080/08923973.2021.2023173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary immunodeficiency diseases (PIDs) consist of a heterogeneous group of genetically disorders that affect distinct components of the immune system. They manifest as increased susceptibility to life-threatening infections, as well as autoimmunity and inflammatory disease. Among them, patients with diseases of immune dysregulation and autoinflammatory disorders are more complicated with autoimmunity. On the other hand, tumor necrosis factor alpha (TNF-alpha) is one of the major players in the pathogenesis of autoimmunity and inflammation in PID patients. Monoclonal antibodies (mAbs) targeting TNF-alpha would be a potential approach as a therapeutic tool for these diseases. In the current review, we aimed to highlight the characteristics of TNF-alpha and its important role in the pathogenesis of related complication in PID diseases. Critical evaluation of the mAbs targeting TNF-alpha (e.g. infliximab, etanercept, and adalimumab) in various immune-mediated complications in PID diseases will be provided, and finally, their clinical efficacy and safety will be reported.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 105 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   Signalling pathways of the TNF superfamily: A double-edged sword [J].
Aggarwal, BB .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :745-756
[3]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[4]   Infliximab therapy for Crohn's-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: A case report [J].
Akazawa Y. ;
Takeshima F. ;
Yajima H. ;
Imanishi D. ;
Kanda T. ;
Matsushima K. ;
Minami H. ;
Yamaguchi N. ;
Ohnita K. ;
Isomoto H. ;
Hayashi T. ;
Nakashima M. ;
Nakao K. .
BMC Research Notes, 7 (1)
[5]  
Al-Mayouf SM, 2017, CLIN EXP RHEUMATOL, V35, P327
[6]   Rheumatologic complications in a cohort of 227 patients with common variable immunodeficiency [J].
Azizi, G. ;
Kiaee, F. ;
Hedayat, E. ;
Yazdani, R. ;
Dolatshahi, E. ;
Alinia, T. ;
Sharifi, L. ;
Mohammadi, H. ;
Kavosi, H. ;
Jadidi-Niaragh, F. ;
Ziaee, V. ;
Abolhassani, H. ;
Aghamohammadi, A. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2018, 87 (05)
[7]   Approach to the Management of Autoimmunity in Primary Immunodeficiency [J].
Azizi, G. ;
Ziaee, V. ;
Tavakol, M. ;
Alinia, T. ;
Yazdai, R. ;
Mohammadi, H. ;
Abolhassani, H. ;
Aghamohammadi, A. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 85 (01) :13-29
[8]   Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity [J].
Azizi, Gholamreza ;
Tavakol, Marzieh ;
Yazdani, Reza ;
Delavari, Samaneh ;
Moeini Shad, Tannaz ;
Rasouli, Seyed Erfan ;
Jamee, Mahnaz ;
Pashangzadeh, Salar ;
Kalantari, Arash ;
Shariat, Mansoureh ;
Shafiei, Alireza ;
Mohammadi, Javad ;
Hassanpour, Gholamreza ;
Chavoshzadeh, Zahra ;
Mahdaviani, Seyed Alireza ;
Momen, Tooba ;
Behniafard, Nasrin ;
Nabavi, Mohammad ;
Bemanian, Mohammad Hassan ;
Arshi, Saba ;
Molatefi, Rasol ;
Sherkat, Roya ;
Shirkani, Afshin ;
Alyasin, Soheila ;
Jabbari-Azad, Farahzad ;
Ghaffari, Javad ;
Mesdaghi, Mehrnaz ;
Ahanchian, Hamid ;
Khoshkhui, Maryam ;
Eslamian, Mohammad Hossein ;
Cheraghi, Taher ;
Dabbaghzadeh, Abbas ;
Nasiri Kalmarzi, Rasoul ;
Esmaeilzadeh, Hossein ;
Tafaroji, Javad ;
Khalili, Abbas ;
Sadeghi-Shabestari, Mahnaz ;
Darougar, Sepideh ;
Moghtaderi, Mojgan ;
Ahmadiafshar, Akefeh ;
Shakerian, Behzad ;
Heidarzadeh, Marzieh ;
Ghalebaghi, Babak ;
Fathi, Seyed Mohammad ;
Darabi, Behzad ;
Fallahpour, Morteza ;
Mohsenzadeh, Azam ;
Ebrahimi, Sarehsadat ;
Sharafian, Samin ;
Vosughimotlagh, Ahmad .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, 32 (06) :1335-1348
[9]   Abnormality of regulatory T cells in common variable immunodeficiency [J].
Azizi, Gholamreza ;
Hafezi, Nasim ;
Mohammadi, Hamed ;
Yazdai, Reza ;
Alinia, Tina ;
Tavakol, Marzieh ;
Aghamohammadi, Asghar ;
Mirshafiey, Abbas .
CELLULAR IMMUNOLOGY, 2017, 315 :11-17
[10]   Autoimnriunity in Primary Antibody Deficiencies [J].
Azizi, Gholamreza ;
Ahmadi, Moslem ;
Abolhassani, Hassan ;
Yazdani, Reza ;
Mohammadi, Hamed ;
Mirshafiey, Abbas ;
Rezaei, Nima ;
Aghamohammadi, Asghar .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 171 (3-4) :180-193